Best Sequence Alternative for GLP-1 in 2026
Exploring the best alternatives to Sequence for GLP-1 weight loss treatment. Compare providers that offer equivalent medications and medical oversight at significantly lower monthly costs without contract commitments.
More on GLP-1 Provider Comparisons
Why Patients Seek Sequence Alternatives
Sequence has positioned itself as a premium, science-forward GLP-1 weight loss platform with genetic testing and personalized treatment protocols. While this approach appeals to a specific patient segment, a growing number of Sequence users are discovering that the premium pricing — $199 to $399 per month — may not translate to proportionally better outcomes compared to more affordable alternatives offering the same core medication.
The financial reality of GLP-1 treatment is that most patients need twelve to eighteen months of continuous therapy to achieve and begin maintaining meaningful weight loss. At Sequence's pricing, this represents a commitment of $2,400 to $7,200 — a substantial financial investment that many patients find difficult to sustain, especially when they realize that the compounded semaglutide or tirzepatide they receive is pharmacologically identical to what lower-cost providers offer.
Contract commitments add another layer of friction. Unlike month-to-month providers where patients can pause or stop at any time, Sequence's multi-month commitments create financial and logistical barriers to switching. Patients who signed up during an optimistic moment may find themselves locked into paying for a premium they no longer feel is justified — a situation that drives both frustration and the search for alternatives.
Top Sequence Alternatives Compared
| Factor | Sequence | Trimi | Found | Calibrate |
|---|---|---|---|---|
| Monthly cost (semaglutide) | $199–$349/mo | $99/mo | $129–$249/mo | $300+/mo |
| Genetic testing | Yes | No | No | Metabolic testing |
| Contract required | Yes (3–6 mo) | No | Varies | Yes (12 mo) |
| Flat pricing at all doses | Varies | Yes | No | No |
| Tirzepatide available | Yes | Yes | Yes | Yes |
| 12-month savings vs Sequence | — | $1,200–$3,600 | $0–$1,800 | $0 (more expensive) |
Trimi: The Best Value Alternative to Sequence
For patients leaving Sequence, Trimi represents the strongest combination of clinical quality, pricing transparency, and treatment flexibility. Trimi's model directly addresses the primary complaints that drive patients away from Sequence: unsustainable pricing, inflexible contracts, and the realization that premium bundling may not improve clinical outcomes.
Trimi's semaglutide program at $99 per month delivers the same compounded medication from FDA-registered pharmacies with board-certified provider oversight. The flat pricing eliminates dose-dependent cost increases, and the month-to-month structure means you are never locked into paying for a service that no longer meets your needs. For patients switching from Sequence, the savings of $100 to $300 per month begin immediately and compound throughout the remaining treatment course.
Same compounded semaglutide and tirzepatide at 50–75% less than Sequence
No contract — month-to-month flexibility with zero cancellation penalties
Flat pricing regardless of medication dose
Board-certified providers with responsive clinical support
Seamless transition for patients already on GLP-1 therapy
No bundled services you do not need or use
Found as a Sequence Alternative
Found sits between Sequence and Trimi in pricing and features. Found's app-based behavioral coaching platform provides more supplementary features than Trimi, though less specialized than Sequence's genetic approach. Found's semaglutide pricing of $129 to $249 per month is lower than Sequence but higher than Trimi, and its dose-dependent pricing means costs increase during treatment.
For Sequence patients who want some level of app-based support but at lower cost, Found is a reasonable middle ground. However, patients who are primarily motivated by cost savings will find that Found's savings over Sequence are modest compared to the savings available through Trimi. And patients who valued Sequence's genetic testing will not find an equivalent feature at Found. For a detailed Found analysis, see our Found semaglutide cost breakdown.
How to Choose the Right Sequence Alternative
If maximum savings is your priority
Trimi at $99/month provides the largest cost reduction while maintaining equivalent clinical care and identical medication. Annual savings of $1,200 to $3,600 versus Sequence.
If you want app-based coaching at moderate cost
Found offers behavioral tools and meal tracking at $129–$249/month — more than Trimi but less than Sequence. Suitable if you actively use app-based coaching features.
If you want an even more intensive program
Calibrate offers a comprehensive metabolic program with intensive coaching — but at $300+/month with a 12-month contract. Only appropriate if budget is not a primary concern.
If you want to preserve genetic testing capabilities
Consider obtaining independent genetic testing (one-time cost) while using an affordable GLP-1 provider like Trimi for ongoing treatment. This gives you genetic data without paying Sequence's monthly premium.
Ready to make the switch? Our guide to switching from Sequence to Trimi walks through every step. If you are still evaluating, the Sequence vs Trimi pricing comparison provides detailed financial analysis to inform your decision.
Frequently Asked Questions
What is the best alternative to Sequence for GLP-1 treatment?
Trimi is the leading alternative to Sequence for patients seeking the same GLP-1 medications at significantly lower prices. Trimi offers compounded semaglutide starting at $99 per month and tirzepatide at competitive rates — compared to Sequence's $199 to $399 per month range. Both providers use FDA-registered compounding pharmacies and board-certified providers. Trimi's month-to-month flexibility and flat dose-independent pricing further differentiate it from Sequence's contract-based model.
Why do patients leave Sequence?
Patients leave Sequence for several reasons: the premium pricing is difficult to sustain over a twelve to eighteen month treatment course, contract commitments reduce flexibility, and some patients conclude that the genetic testing and platform features do not meaningfully improve their outcomes compared to standard GLP-1 management. The realization that the same medication is available at half the price from other reputable providers is often the tipping point for switching.
Do I lose access to my genetic data if I leave Sequence?
You should request a copy of your genetic test results before canceling Sequence. Under most circumstances, you are entitled to your medical records and test results. This data remains useful even if you switch providers — you can share it with your new provider for informational purposes. However, most standard GLP-1 treatment protocols do not require genetic data, so the absence of this information at a new provider like Trimi will not affect your treatment quality.
Is Sequence's genetic testing worth staying for?
Sequence's genetic testing provides interesting biological data, but its practical impact on GLP-1 treatment outcomes has not been established in large clinical trials. Standard dose titration protocols effectively personalize treatment through clinical observation — monitoring your response and adjusting accordingly. If the genetic data provides you with motivation or psychological comfort, that has value. But if you are staying solely because of the genetic testing while paying $100 to $300 more per month, the financial math does not support that decision for most patients.
Can I get genetic testing independently and use a cheaper GLP-1 provider?
Yes, direct-to-consumer genetic testing services can provide pharmacogenomic data at a one-time cost that is far less than what you pay in Sequence premiums over multiple months. You can then use this data informally when discussing treatment with any GLP-1 provider. This approach gives you the genetic information without tying it to an expensive ongoing subscription.
How does switching from Sequence work?
Switching from Sequence to another provider follows a straightforward process: start onboarding with your new provider while you still have Sequence medication remaining, complete a medical intake and provider consultation, receive your new medication, and then cancel Sequence. Most transitions take three to seven days when well-timed. Be aware of any contract obligations with Sequence that may affect the timing or cost of your departure.
Will my new provider continue my current Sequence medication and dose?
Yes, reputable GLP-1 providers including Trimi will continue your current medication type and dose when you transfer. There is no clinical reason to restart dosing or switch medications simply because you changed providers. Your new provider will review your treatment history and maintain continuity of care. The transition should feel seamless from a medical standpoint.
Sources & References
- Sequence. Official pricing and program information. 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
- Roden DM, et al. "Pharmacogenomics." The Lancet, 2019;394(10197):521-532.
- American Board of Obesity Medicine. "Standards of Practice." 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing directly with each provider.